Skip to main content
Clinical Trials/IRCT20160206026406N3
IRCT20160206026406N3
Recruiting
Phase 3

Comparison of the effect of the calcium citrate supplement with normal calcium diet on metabolic risk factors in recurrent calcium stone formers with hyperoxaluria: a randomized clinical trial

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Recurrent calcium stone formers with hyperoxaluria.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
66
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Recurrent stone former
  • Hyperoxaluria (24hr Urine Oxalate between 40\-80 mg)
  • Baseline dietary calcium intake less than 800 mg/day
  • The desire to collaborate in the study

Exclusion Criteria

  • Enteric or primary hyperoxaluria (24 hours urine oxalate more than 80 mg)
  • Taking Thiazides or any medicine that has an effect on calcium metabolism
  • Taking any medicine that has an effect on oxalate metabolism
  • Taking vitamin B6
  • Hepatitis, diabetes, thyroid diseases, hyperparathyroidism, immunological diseases, cancers, chronic diarrhea, chronic kidney diseases and urinary tract infection
  • Pregnancy and lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials